Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19 products and a number of its cancer drugs.
from US Top News and Analysis https://ift.tt/lIqBoyT
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
April 23, 2024
0
